Citadel Advisors »

Marker Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Marker Therapeutics (MRKR) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Marker Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Marker Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Marker Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $88k 59k 1.49
2024-09-30 $37k 13k 2.82

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
Spdr Gold Tr Gold Shs Call Option (GLD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Advanced Micro Devices Call Option (AMD)

View all positions for Citadel Advisors

Top funds holding Marker Therapeutics

NEA Management Company
Blue Owl Capital Holdings
Vanguard Group
Aisling Capital Management
Goss Wealth Management
Geode Capital Management
Renaissance Technologies
Two Sigma Investments
Advisor Group Holdings
LPL Financial
Citadel Advisors
XTX Topco
Jane Street
UBS Group
Invst

View all funds holding Marker Therapeutics